Tirzepatide
60mg
High-concentration tirzepatide (60mg) lyophilized vial for research applications requiring extended dosing protocols or larger animal models. Same dual GIP/GLP-1 receptor agonist compound as the 30mg formulation. The increased concentration per vial reduces reconstitution frequency and is suited for chronic administration studies. Refer to the tirzepatide 30mg product listing for complete pharmacological profile and citations.
Pricing
Mechanism of Action
Identical mechanism to tirzepatide 30mg — dual GIP/GLP-1 receptor co-agonism with preferential GIPR binding affinity. See tirzepatide 30mg listing for full mechanistic details.
Properties
Molecular Weight
4813.45 Da
Half-Life
~5 days
Storage
Store lyophilized at -20°C. Reconstituted at 2-8°C, use within 30 days.
Research Applications
References & Citations
(1)Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
Jastreboff AM, Aronne LJ, Ahmad NN, et al.
Related Products
Research Use Only
This product is intended strictly for in-vitro research, educational, and laboratory use. Not for human consumption. The information provided is based on published research and does not constitute medical advice.